Study of disorder on acute phase proteins in patients with Multiple Sclerosis
Study of disorder on acute phase proteins in patients with Multiple Sclerosis
Study of disorder on acute phase proteins in patients with Multiple Sclerosis
KOUNDOURIS D.2, DROSSOS TH1, SIANI A1, AND ANOUSIS S1
1Pammakaristos Hospital, Iakovaton 43, 11144 Athens, Greece
2Neurological Medical Centrer, Athens Greece
Objectives: In this work we studied the variations in some proteins in patients with MS. These proteines are increased in some neoplastic, collagen and inflammatory diseases. The proteins C3, C4 (complement) CRP (c reactive protein) A1 AT (a1 antitrypsine) A2MG (a2 macroglobulin) and RF rheumatoid factor.
Materials and methods: Twenty volunteer patients with MS participate in this study. Fourteen women and 6 men aged 21-53 years. The measurement of proteinic fraction C3, C4, CRP,A2AT,A1MG and RF performed with specific reactive source (Sanofi).
Result:
C3
129.02
I
(101-202 mg/dl)
C4
27.61
II
(16-47 mg/dl)
CRP
<5.5
III
(<8 mg/dl)
A1AT
267.1
IV
(103-203 mg/dl)
A2MG
167.1
V
(120-321 mg/dl)
R.F.
<40 IU/ml
VI
(R.F. ,40 IU/ml)
Conclusions: No changes found in complement C3 C4. No change also found in CRP AND A1AT increased in all patients with MS. Conclusively the question if the increased A1AT (an a1 globulin fraction) is a reliable index of CUTE Ms have to be further evaluated.
Από την εποχή του Ιπποκράτη, οι γιατροί είναι συνεχώς σε μία προσπάθεια να βρουν λύσεις για καινούργιες αναλγητικές εφαρμογές στους έντονους πόνους. Περισσότερα...
Παρακολουθούν τώρα*
Terra Incognita - Kontra Channel - Δογμα ΣΟΚ
*Ο Δρ. Δημήτρης Κουντούρης έχει συμμετάσχει σε πολλές τηλεοπτικές εκπομπές σαν ειδικός επιστημονικός σύμβουλος επί θεμάτων Νευρολογίας και Ψυχιατρικής. Για πλήρη λίστα των τηλεοπτικών εκπομπών μπορείτε να επισκεφτείτε και το κανάλι μας στο YouTube: Neurology Channel
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish.AcceptRead More
Privacy & Cookies Policy
Privacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.